Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 202-210

  Bercovici, Nadège ^a,c   Heurtier, Agnès ^a   Vizler, Csaba ^a   Pardigon, Nathalie ^a   Cambouris, Christophe ^a,c   Desreumaux, Pierre ^b   Liblau, Roland ^a  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Immuno Designed Molecules   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CELLULAR IMMUNITY; DISEASE COURSE; DOWN REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; JUVENILE DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0034234485     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.202     Document Type: Article

References (67)

1. Liblau, R., R. Tisch, N. Bercovici, and H. O. McDevitt. 1997. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol. Today 18: 599.
2. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
3. Tisch, R., X. D. Yang, R. S. Liblau, and H. O. McDevitt. 1994. Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J. Autoimmun. 7:845.
4. Tian, J., M. Clare-Salzler, A. Herschenfeld, B. Middleton, D. Newman, R. Mueller, S. Arita, C. Evans, M. A. Atkinson, Y. Mullen, et al. 1996. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1348.
5. Tisch, R., R. S. Liblau, X. D. Yang, P. Liblau, and H. O. McDevitt. 1998. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47:894.
6. Gaur, A., B. Wiers, A. Liu, J. Rothbard, and C. G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491.
7. Critchfield, J. M., M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman, and M. J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 261:1139.
8. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankerstein, R. Martin, U. Utz, N. Karin, and D. Mitchell. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379: 343.
9. Samson, M. F., and D. E. Smilek. 1995. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J. Immunol. 155:2737.
10. Masuric, S., and S. Tonegawa. 1997. Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide. J. Exp. Med. 186:507.
11. Tisch, R., B. Wang, and D. V. Serreze. 1999. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163:1178.
12. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
13. Von Herrath, M. G., J. Dockter, and M. B. Oldstone. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231.
14. Wong, F. S., I. Visintin, L. Wen, R. A. Flavell, and C. A. Janeway, Jr. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183:67.
15. + T cells in organ-specific autoimmune diseases: insight from transgenic mouse models. Immunol. Rev. 169:81.
16. 2m null mice are diabetes and insulitis resistant. Diabetes 43:505.
17. 2-microglobulin null nonobese diabetic mice. J. Immunol. 157:3688.
18. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:1762.
19. DiLorenzo, T. P., R. T. Graser, T. Ono, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 1998. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95:12538.
20. Kagi, D., B. Odermatt, P. S. Ohashi, R. M. Zinkernagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183:2143.
21. Kagi, D., B. Odermatt, P. Seiler, R. M. Zinkernagel, T. W. Mak, and H. Hengartner. 1997. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186:989.
22. Aichele, P., D. Kyburz, P. S. Ohashi, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1994. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 91:444.
23. Von Herrath, M. G., B. Coon, H. Lewicki, H. Mazarguil, J. E. Gairin, and M. B. A. Oldstone. 1998. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J. Immunol. 161: 5087.
24. Aichele, P., K. Brduscha-Riem, S. Oehen, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1997. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6:519.
25. + T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157:978.
26. + T cells. Eur. J. Immunol. 22:1013.
27. Bercovici, N., J. Delon, C. Cambouris, N. Escriou, P. Debre, and R. S. Liblau. 1999. Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice. Eur. J. Immunol. 29:345.
28. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled Annexin V. J. Immunol. Methods 184:39.
29. + T cell activation. Int. Immunol. 10:619.
30. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
31. Liblau, R. S., R. Tisch, K. Shokat, X. Yang, N. Dumont, C. C. Goodnow, and H. O. McDevitt. 1996. Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc. Natl. Acad. Sci. USA 93:3031.
32. Koniaras, C., S. R. Bennett, F. R. Carbone, W. R. Heath, and A. M. Lew. 1997. Peptide-induced deletion of CD8 T cells in vivo occurs via apoptosis in situ. Int. Immunol. 9:1601.
33. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207.
34. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34.
35. Blanas, E., F. R. Carbone, J. Allison, J. F. Miller, and W. R. Heath. 1996. Induction of autoimmune diabetes by oral administration of autoantigen. Science 274:1707.
36. Verdaguer, J., D Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663.
37. Kyburz, D., P. Aichele, D. E. Speiser, H. Hengartner, R. M. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956.
38. Mamalaki, C., Y. Tanaka, P. Cornella, P. Chandler, E. Simpson, and D. Kioussis. 1993. T cell deletion follows chronic antigen specific T cell activation in vivo. Int. Immunol. 5:1285.
39. Pearson, C. I., W. v. Ewijk, and H. O. McDevitt. 1997. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J. Exp. Med. 185:583.
40. Huang, L., G. Soldevila, M. Leeker, R. Flavell, and I. N. Crispe. 1994. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1:741.
41. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
42. + T cells can persist and function in vivo. J. Immunol. 163:155.
43. + T cells become nonresponsive (anergic) following activation in the presence of costimulation. J. Immunol. 163:102.
44. Dubois, P. M., M. Pihlgren, M. Tomkowiak, M. Van Mechelen, and J. Marvel. 1998. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo. J. Immunol. 161:5260.
45. Katz, J., C. Benoist, and D. Mathis. 1993. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23:3358.
46. + T-cell clones in vivo. Diabetes 45:1121.
47. Weishaupt, A., R. Gold, S. Gaupp, G. Giegerich, H. P. Hartung, and K. V. Toyka. 1997. Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2. Proc. Natl. Acad. Sci. USA 94:1338.
48. Ishigami, T., C. A. White, and M. P. Pender. 1998. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. Eur. J. Immunol. 28:1626.
49. Kurrer, M. O., S. V. Pakala, H. L. Hanson, and J. D. Katz. 1997. β cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:213.
50. Augstein, P., L. A. Stephens, J. Allison, A. G. Elefanty, M. Ekberg. T. W. Kay, and L. C. Harrison. 1998. β-cell apoptosis in an accelerated model of autoimmune diabetes. Mol. Med. 4:495.
51. Pilarski, L. M. 1977. Ontogeny of cell-mediated immunity. I. Early developpment of alloantigen-specific cytotoxic T-cell precursors in postnatal mice. J. Exp. Med. 146:887.
52. Piguet, P. F., C. Irle, E. Kollatte, and P. Vassalli. 1981. Post-thymic T lymphocyte maturation during ontogenesis J. Exp. Med. 154:581.
53. Sarzotti, M., D. S. Robbins, and P. M. Hoffman. 1996. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271:1726.
54. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of TH4 and TH2 immunity in neonatal mice. Science 271:1728.
55. Min, B., K. L. Legge, C. Pack, and H. Zaghouani. 1998. Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon γ-mediated splenic anergy. J. Immunol. 188:2007.
56. Lu, C. Y., E. G. Calamai, and E. R. Unanue. 1979. A defect in the antigen-presenting function of macrophages from neonatal mice. Nature 282:327.
57. Lu, C. Y., D. I. Beller, and E. R. Unanue. 1980. During ontogeny, Ia-bearing accessory cells are found early in the thymus but late in the spleen. Proc. Natl. Acad. Sci. USA 77:1597.
58. Rafii-Tabar, E., and A. A. Czitrom. 1986. Ontogeny of priming of cytotoxic T cells to minor alloantigens: the development of direct priming precedes that of cross-priming. Eur. J. Immunol. 16:1025.
59. Levin, D., and H. Gershon. 1989. Antigen presentation by neonatal murine spleen cells. Cell. Immunol. 120:132.
60. Morris, J. F., J. T. Hoyer, and S. K. Pierce. 1992. Antigen presentation for T cell interleukin-2 secretion is a late acquisition of neonatal B cells. Eur. J. Immunol. 22:2923.
61. Piguet, P. F., C. Irle, and P. Vassalli. 1981. Immunosuppressor cells from newborn mouse spleen are macrophages differentiating in vitro from monoblastic precursors. Eur. J. Immunol. 11:56.
62. Adkins, B., A. Ghanei, and K. Hamilton. 1994. Up-regulation of murine neonatal T helper cell responses by accessory cell factors. J. Immunol. 153:3378.
63. Sarukhan, A., A. Lanoue, A. Franzke, N. Brousse, J. Buer, and H. von Boehmer. 1998. Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J. 17:71.
64. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
65. + T cells from nonobese diabetic mice use highly homologous T cell receptor α-chain CDR3 sequences. J. Immunol. 154:2494.
66. + T cell response against one peptide/MHC complex in autoim* mune diabetes. Proc. Natl. Acad. Sci. USA 96:9311.
67. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway. 1999. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5:1026.